ADPD 2023 Conference Highlights - Part 1

Published: April 10, 2023, midnight

This year's AD/PD Conference was held in Gothenburg, Sweden from the 28th March to 1st April. In this first of a two-part special we bring you highlights from the first three days of the conference.\n\nThe AD/PD Conference focuses on basic science and translational and clinical research bringing New insights on disease mechanisms and etiologies, the latest findings from clinical trials, innovative outlooks on therapy and prevention and advances in diagnostic markers.\n\nIn this special on-location recording our guest host Dr Nikoleta Daskoulidou, Research Associate from the UK Dementia Research Institute at Cardiff University talks with:\n\nDr David J. Koss, Research Associate from Newcastle University. David is working to understand the molecular pathology which underpins a range of neurodegenerative dementias.\n\nDr Susan Mitchell, Head of Policy at Alzheimer\u2019s Research UK. Susan is part of the ARUK policy and public affairs team, with responsibility for developing evidence-based policy to ensure people affected by dementia benefit from the progress in research.\n\nElizabeth English, PhD Student at University of Cambridge. Lizzie, is utilising biophysical methods to characterise protein aggregates and their toxicity mechanisms in neurodegenerative disease.\n\nFor more information on the event visit:\nhttps://adpd.kenes.com/\n\nFull biographies on all our guests and a transcript can be found on our website:\nhttps://www.dementiaresearcher.nihr.ac.uk\n\nLike what you hear? Please review, like, and share our podcast - and don't forget to subscribe to ensure you never miss an episode \u2013 and if you prefer to watch rather than listen, you\u2019ll find a video version of this podcast on our YouTube Channel\n\nhttps://youtu.be/UQdm8aWuoFM\n\nThis podcast is brought to you by University College London / UCLH NIHR Biomedical Research Centre in association with Alzheimer\u2019s Association, Alzheimer's Research UK, Alzheimer's Society and Race Against Dementia who we thank for their ongoing support.